Brompheniramine Completed Phase 1 Trials for Allergic Reaction Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00894634Study Evaluating Brompheniramine Maleate Liquid in Children and Adolescents